VH032-NH2 hydrochloride
|
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐
|
1448189-80-7
|
Ursocholic acid
|
熊果胆酸
|
2955-27-3
|
DC661
|
DC661
|
1872387-43-3
|
SM 16
|
SM16
|
614749-78-9
|
GSK-4716
|
GSK 4716
|
101574-65-6
|
Selitrectinib
|
LOXO-195
|
2097002-61-2
|
AZD5582
|
AZD 5582
|
1258392-53-8
|
Ezatiostat
|
EZATIOSTAT游离的
|
168682-53-9
|
BK-1361
|
cyclo-RLsKDK)
|
1975145-82-4
|
CVT-10216
|
3-[[[3-[4-[(甲基磺酰基)氨基]苯基]-4-氧代-4H-苯并吡喃-7-基]氧基]甲基]苯甲酸
|
1005334-57-5
|
FEMA 4774
|
浅黄色至白色固体
|
1359963-68-0
|
GSK2795039
|
1415925-18-6
|
1415925-18-6
|
Resmetirom
|
MGL-3196
|
920509-32-6
|
2,9-dibromo-1,10-phenanthroline-5,6-dione
|
2,9-二溴-1,10-菲罗啉-5,6-二酮
|
943861-95-8
|
FG-2216
|
BIQ
|
223387-75-5
|
TLR1
|
N-[(1S)-2-甲基-1-(1-吡咯烷羰基)丙基]-苯丙酰胺
|
566914-00-9
|
Clenbuterol hydrochloride
|
盐酸克仑特罗
|
21898-19-1
|
Piperazine Erastin
|
PIPERAZINE ERASTIN
|
1538593-71-3
|
Recilisib sodium
|
RECILISIB SODIUM(钠盐)
|
922139-31-9
|
EPZ011989
|
化合物EPZ011989
|
1598383-40-4
|
DPN
|
2,3-双(4-羟苯基)丙腈
|
1428-67-7
|
RWJ-67657
|
4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
|
215303-72-3
|
M4284
|
M 4284)
|
1373346-85-0
|
GSK2838232
|
HIV-RT抑制剂1
|
1443460-91-0
|
Evocalcet
|
伊万卡赛
|
870964-67-3
|
Plerixafor octahydrochloride
|
盐酸普乐沙福
|
155148-31-5
|
5-R-Rivaroxaban
|
5-R-利伐沙班
|
865479-71-6
|
AZ505
|
N-环己基-3-(3,4-二氯苯乙基氨基)-N-[2-[[2-[5-羟基-3-氧代-3,4-二氢-2H-苯并[B][1,4]恶嗪-8-基]乙基]氨基]乙基]丙酰胺
|
1035227-43-0
|
Metaraminol tartrate
|
重酒石酸间羟胺
|
33402-03-8
|
MMV390048
|
化合物MMV390048
|
1314883-11-8
|
Saracatinib
|
塞卡替尼
|
379231-04-6
|
DM4
|
N2'-去乙酰基-N2'-(4-巯基-4-甲基-1-氧代戊基)-美登素
|
796073-69-3
|
Anle138b
|
3-(1,3-苯并二恶唑-5-基)-5-(3-溴苯基)-1H-吡唑
|
882697-00-9
|
GW806742X
|
CS-2659
|
579515-63-2
|
SPR741
|
SPR-741
|
1179330-52-9
|
Murepavadin
|
莫瑞伐定
|
944252-63-5
|
LY3202626
|
化合物 T27944
|
1628690-73-2
|
AC-ALA-ALA-PRO-PHE-PNA
|
AC-ALA-ALA-PRO-PHE-PNA
|
70967-94-1
|
BI-4924
|
Acetic acid, 2-[[4-[(1S)-1-[[(4,5-dichloro-1,6-dimethyl-1H-indol-2-yl)carbonyl]amino]-2-hydroxyethyl]phenyl]sulfonyl]-
|
2244452-09-1
|
Velneperit
|
韦利贝特
|
342577-38-2
|
Rilzabrutinib
|
瑞扎布鲁替尼
|
1575596-29-0
|
FPH1
|
FPH1(BRD-6125)
|
708219-39-0
|
ART558
|
化合物ART558
|
2603528-97-6
|
Ac-Lys-Gln-Lys-Leu-Arg-AMC
|
Ac-Lys-Gln-Lys-Leu-Arg-AMC
|
1135686-31-5
|
Ingliforib
|
CPD2802
|
186392-65-4
|
DECANOYL-ARG-VAL-ARG-LYS-CHLOROMETHYLKETONE
|
DECANOYL-ARG-VAL-ARG-LYS-CHLOROMETHYLKETONE
|
534615-50-4
|
Opicapone
|
奥匹卡朋
|
923287-50-7
|
PD 90780
|
7-(BENZOYLAMINO)-4,9-DIHYDRO-4-METHYL-9-OXO-PYRAZOLO[5,1-B]QUINAZOLINE-2-CARBOXYLIC ACID
|
77422-99-2
|
BAY-6035
|
BAY-6035
|
2247890-13-5
|
MYCi975
|
MYCi975
|
2289691-01-4
|
MRTX-1719
|
MRTX-1719
|
2630904-45-7
|
TAS-119
|
化合物 T34787
|
1453099-83-6
|
BAR502
|
BAR 502
|
1612191-86-2
|
ARS-1620
|
CPD1588
|
1698055-85-4
|
Galloflavin
|
培黄素
|
568-80-9
|
DS-7423
|
DS 7423)
|
1222104-37-1
|
Ac-DEVD-pNA
|
AC-ASP-GLU-VAL-ASP-PNA
|
189950-66-1
|
Proteasome Substrate II
|
N-[(苯基甲氧基)羰基]-L-亮氨酰-L-亮氨酰-N-(4-甲基-2-氧代-2H-1-苯并吡喃-7-基)-L-ALPHA-谷氨酰胺
|
348086-66-8
|
DUPA(OtBu)-OH
|
4,6,12,19-Tetraazadocosane-1,3,7-tricarboxylic acid, 22-[3-[[[2-[[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl](carboxymethyl)amino]ethyl](carboxymethyl)amino]methyl]-4-hydroxyphenyl]-5,13,20-trioxo-, (3S,7S)-
|
1366302-52-4
|
BZ-NLE-LYS-ARG-ARG-AMC
|
BZ-NLE-LYS-ARG-ARG-AMC
|
863975-32-0
|
PD-1-IN-17
|
PD-1-IN-17
|
1673560-66-1
|
BAY-899
|
化合物 T10476
|
2471967-92-5
|
CBS9106
|
CBS-9106
|
1076235-04-5
|
Ac-IETD-AMC
|
Ac-Ile-Glu-Thr-Asp-AMC
|
348079-17-4
|
Evofosfamide
|
N,N'-双(2-溴乙基)二氨基膦酸 (1-甲基-2-硝基-1H-咪唑-5-基)甲酯
|
918633-87-1
|
Mirogabalin
|
米洛巴林
|
1138245-13-2
|
PZM21
|
PZM-21
|
1997387-43-5
|
Mirogabalin besylate
|
10928苯磺酸盐
|
1138245-21-2
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
Pentixafor
|
Pentixafor
|
1341207-62-2
|
GLPG0187
|
GLPG0187, 一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性
|
1320346-97-1
|
Odevixibat
|
Odevixibat
|
501692-44-0
|
CDDO-dhTFEA
|
RTA dh404
|
1191265-33-4
|
Fatostatin
|
FATOSTATIN A
|
125256-00-0
|
Nemorexant
|
奈莫雷生
|
1505484-82-1
|
DYNORPHIN A (1-10)-GLY-CHLOROMETHYLKETONE
|
DYNORPHIN A (1-10)-GLY-CHLOROMETHYLKETONE
|
189002-98-0
|
Palupiprant
|
E-7046
|
1369489-71-3
|
A-966492
|
A-966492
|
934162-61-5
|
Branebrutinib
|
BMS-986195
|
1912445-55-6
|
SUC-ALA-ALA-VAL-AMC
|
SUC-ALA-ALA-VAL-AMC
|
128972-90-7
|
Lanifibranor
|
IVA-337
|
927961-18-0
|
HQ461
|
HQ461
|
1226443-41-9
|
Darexaban
|
N-[2-羟基-6-(4-甲氧基苯甲酰氨基)苯基]-4-(4-甲基-1,4-二氮杂庚烷-1-基)苯甲酰胺
|
365462-23-3
|
Fevipiprant
|
非韦匹仑
|
872365-14-5
|
Eganelisib
|
IPI-549
|
1693758-51-8
|
HS38
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide
|
1030203-81-6
|
AC-DEVD-AMC
|
AC-ASP-GLU-VAL-ASP-7-氨基-4-甲基香豆素
|
169332-61-0
|
(S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid
|
(S)-5-叔丁氧基-4-(3-((S)-1,5-二-叔丁氧基-1,5-二氧代-2-戊基)脲啶)-5-氧代戊酸
|
1026987-94-9
|
Ac-Ile-Glu-Thr-Asp-pNA
|
AC-ILE-GLU-THR-ASP-PNA
|
219138-21-3
|
succinyl-alanyl-alanyl-phenylalanine-4-nitroanilide
|
SUC-ALA-ALA-PHE-PNA
|
61043-53-6
|
VX-984
|
VX-984(M9831)
|
1562396-65-9
|
BI-3406
|
BI-3406
|
2230836-55-0
|
Sec61-IN-1
|
化合物SEC61-IN-1
|
2484865-42-9
|
BAY-3827
|
BAY-3827
|
2377576-35-5
|
AC-PHE-ARG-AMC
|
AC-PHE-ARG-AMC
|
177028-04-5
|
Z-ARG-LEU-ARG-GLY-GLY-AMC
|
Z-ARG-LEU-ARG-GLY-GLY-AMC
|
167698-69-3
|
UROKINASE SUBSTRATE I, COLORIMETRIC
|
Z-VAL-GLY-ARG-PNA
|
78333-16-1
|
Rasarfin
|
化合物RASARFIN
|
674359-73-0
|
19-Hydroxybaccatin III
|
19-HYDROXYBACCATIN III
|
78432-78-7
|
CO23
|
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]-
|
1370363-74-8
|